Key facts
- It has raised $18.2M across 1 recorded rounds; the latest was Later Stage VC (Series A) ($9.0M) in Dec 2021.
- Notable investors include Y Combinator, Metaplanet Holdings, Draper Associates, BDC Capital, Pegasus Tech Ventures — 26 tracked in total.
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 26 names
- ·Watchlist + deal alerts for Kenota Health
Funding rounds
1 roundsAbout Kenota Health
Manufacturer of diagnostic tools designed to be used for allergy testing in humans. The company's tools collect a small blood sample and insert it into streamlined equipment to determine allergen sensitization in a few minutes and print patient test results on the spot, enabling physicians to receive quality diagnostic information and improve patient outcomes.
- Industry
- Diagnostic Equipment
- Sector
- Healthcare
- HQ
- Kitchener, Canada
- Founded
- 2014
- Employees
- 26
- Website
- kenota.com/
- Ownership
- Privately Held (backing)
Kenota Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Kenota Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Kenota Health in its N-PORT filings yet. We sweep new filings monthly.